Literature DB >> 3335698

Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease.

R M Califf1, D B Mark, F E Harrell, M A Hlatky, K L Lee, R A Rosati, D B Pryor.   

Abstract

To examine the value of clinical measures of ischemia for stratifying prognosis, 5,886 consecutive patients who had symptomatic significant (greater than or equal to 75% stenosis) coronary artery disease were studied. Using the Cox regression model in a randomly selected half of the patients, the prognostically independent clinical variables were weighted and arranged into a simple angina score: angina score = angina course X (1 + daily angina frequency) + ST-T changes, where angina course was equal to 3 if unstable or variant angina was present, 2 if the patient's angina was progressive with nocturnal episodes, 1 if it was progressive without nocturnal symptoms and 0 if it was stable; 6 points were added for the presence of "ischemic" ST-T changes. This angina score was then validated in an independent patient sample. The score was a more powerful predictor of prognosis than was any individual anginal descriptor. Furthermore, the angina score added significant independent prognostic information to the patient's age, sex, coronary anatomy and left ventricular function. Patients with three vessel disease and a normal ventricle (n = 1,233) had a 2 year infarction-free survival rate of 90% with an angina score of 0 and a 68% survival rate with an angina score greater than or equal to 9. With an ejection fraction less than 50% and three vessel disease (n = 1,116), the corresponding infarction-free survival figures were 76 and 56%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3335698     DOI: 10.1016/0735-1097(88)90160-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT.

Authors:  S S Sun; J L Huang; S C Tsai; Y J Ho; C H Kao
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

2.  Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study.

Authors:  Caroline A Daly; Bianca De Stavola; Jose L Lopez Sendon; Luigi Tavazzi; Eric Boersma; Felicity Clemens; Nicholas Danchin; Francois Delahaye; Anselm Gitt; Desmond Julian; David Mulcahy; Witold Ruzyllo; Kristian Thygesen; Freek Verheugt; Kim M Fox
Journal:  BMJ       Date:  2006-01-13

3.  Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study).

Authors:  Alexis L Beatty; John A Spertus; Mary A Whooley
Journal:  Am J Cardiol       Date:  2014-07-16       Impact factor: 2.778

4.  Patients' profiles in end stage coronary artery disease. Indications for treatment with transmyocardial laser revascularisation.

Authors:  R C Funck; L Rybinski; H König; K Welzel; A Holland; K Ketteler; F Farokhzad; H Höffken; C Bethge; R Moosdorf; B Maisch
Journal:  Herz       Date:  1997-08       Impact factor: 1.443

5.  Predictors allowing early discharge after interventional treatment of acute coronary syndrome patients.

Authors:  Dávid Bauer; Marek Neuberg; Markéta Nováčková; Petr Mašek; Viktor Kočka; Zuzana Moťovská; Petr Toušek
Journal:  Eur Heart J Suppl       Date:  2022-03-30       Impact factor: 1.624

6.  One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors.

Authors:  Thomas M Maddox; Kimberly J Reid; John S Rumsfeld; John A Spertus
Journal:  BMC Cardiovasc Disord       Date:  2007-09-12       Impact factor: 2.298

7.  Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.

Authors:  Alon Eisen; Deepak L Bhatt; P Gabriel Steg; Kim A Eagle; Shinya Goto; Jianping Guo; Sidney C Smith; E Magnus Ohman; Benjamin M Scirica
Journal:  J Am Heart Assoc       Date:  2016-09-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.